CompoAtlas

LYMPHO2

Food supplement declared in France, declaration No 2018-12-902, decision dated 18 December 2018

LYMPHO2 (REGENERESCENCE) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
REGENERESCENCE
Food business operator placing the product on the market
IE SERVICES
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
4 gélules par jour
Directions for use
A boire avec un grand verre d'eau, de préférence le matin
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Circulation sanguine et lymphatique, Immunité
Flavourings
/

Declaration 292744, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Galium aparine L.FeuilleExtrait sec aqueux1,500 mg
Trigonella foenum-graecum L.GraineExtrait sec hydroalcoolique240 mg
Aesculus hippocastanum L.GraineExtrait sec hydroalcoolique50 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Picolinate de zincZinc25 mg15 mg

Additives

E414, E551

Other ingredients

Extrait de riz, Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2018. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Déconseiller aux femmes enceintes et allaitantes, aux personnes sous traitement anticoagulant.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : REGENERESCENCE

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line